Indium In-111-DOTA-di-HSG Peptide IMP-288
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Radiopharmaceutical Compound ->
Radioconjugate -> Indium In-111-DOTA-di-HSG Peptide IMP-288
Indium In-111-DOTA-di-HSG Peptide IMP-288 Definition
A radiolabeled divalent histamine-succinyl-glycine (HSG) hapten-peptide linked with the macrocyclic chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) to the radionuclide indium (In) 111. After pretargeting with a bispecific monoclonal antibody (BiMoAB) directed against both a tumor associated antigen (TAA) and the HSG hapten-peptide, the HSG portion of administered indium-In-labeled di-HSG-DOTA peptide IMP-288 binds the anti-HSG portion of the BiMoAB; In-111 radioisotopic activity localized to tumor cells bearing the TAA can then be visualized scintigraphically.
Indium In-111-DOTA-di-HSG Peptide IMP-288 Synonyms
Indium In-111-DOTA-di-HSG Peptide IMP-288, In-111-Labeled Di-Histamine-Succinyl-Glycine-DOTA Peptide IMP-288, In-111-Labeled IMP-288
Terms in Indium In-111-DOTA-di-HSG Peptide IMP-288 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.